Table-II.
Fetal and Maternal outcomes Group A v/s B (n=50).
| Fetal outcomes | Group-A (n=25) | Group-B (n=25) | P- value |
|---|---|---|---|
| Mean±SD | Mean±SD | ||
| Weight of the baby (kg) | 3.14±0.32 | 3.44±0.46 | 0.01* |
| Apgar score | 8.64±0.56 | 8.22±2.43 | 0.39 |
| n (%) | n (%) | ||
| Delivery age | 0.021* | ||
| 37 weeks | 19(76%) | 11(44%) | |
| 38 weeks | 6(24%) | 14(56%) | |
| Condition of baby | 0.49@ | ||
| Alive baby | 25(100%) | 23(96%) | |
| Intrauterine death | 0 | 2(8%) | |
| Still birth | 0 | 0 | |
| Maternal outcomes | Mean±SD | Mean±SD | |
| HbA1C-2 (%) (36weeks) | 5.42±0.34 | 5.72±0.35 | 0.003* |
| FBS -2 (36 weeks) | 93.48±11.9 | 102.08±20.63 | 0.079 |
| n (%) | n (%) | ||
| Mode of delivery | NA | ||
| Normal vaginal | 7(28%) | 5(20%) | |
| Assisted delivery | 2(8%) | 3(12%) | |
| Cesarean section | 16(64%) | 17(68%) | |
| Cesarean due to bad obstetric history | 14(56%) | 10(40%) | |
| Cesarean due to Feto–maternal disproportion | 2(8%) | 7(28%) | |
Group-A: Metformin with diet control and exercise, Group-B: Insulin with diet control and exercise, HbA1C-2: Glycated hemoglobin at 36 weeks, FBS-2: fasting blood sugar at 36 weeks,
*
statistically significant result (chi square and independent T test applied), NA: chi-square test not applicable, @: Fisher exact test applied.